Genelux Corp (GNLX)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart
Ticker: GNLX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Total value Details
2024-05-01 2024-05-01 S Sale

Szalay Aladar

Major owner
1,000 -2.7%
3.30
100,000 USD 		1,000 -2.7% 3.30 100,000 USD
2024-05-01 2024-04-30 S Sale

Szalay Aladar

Major owner
1,000 -1.6%
3.12
100,000 USD 		1,000 -1.6% 3.12 100,000 USD
2024-05-01 2024-04-29 S Sale

Szalay Aladar

Major owner
1,000 -0.5%
3.25
100,000 USD 		1,000 -0.5% 3.25 100,000 USD
2024-04-24 2024-04-24 S Sale

Szalay Aladar

Major owner
1,000 -0.6%
3.50
100,000 USD 		1,000 -0.6% 3.50 100,000 USD
2024-04-24 2024-04-23 S Sale

Szalay Aladar

Major owner
1,000 -1.7%
3.49
100,000 USD 		1,000 -1.7% 3.49 100,000 USD
2024-04-24 2024-04-22 S Sale

Szalay Aladar

Major owner
1,000 -1.1%
3.53
100,000 USD 		1,000 -1.1% 3.53 100,000 USD
2024-04-18 2024-04-17 S Sale

Szalay Aladar

Major owner
22,737 -1.7%
3.71
84,425 USD 		22,737 -1.7% 3.71 84,425 USD
2024-04-18 2024-04-16 S Sale

Szalay Aladar

Major owner
48,683 -3.5%
3.53
171,802 USD 		48,683 -3.5% 3.53 171,802 USD
2023-12-18 2023-12-15 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
5,803 -100.0%
14.18
82,265 USD 		5,803 -100.0% 14.18 82,265 USD
2023-12-18 2023-12-15 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
26,732 -82.2%
12.94
345,915 USD 		26,732 -82.2% 12.94 345,915 USD
2023-12-14 2023-12-13 S Sale

Thomas John

Non-Executive Director
1,927 -0.4%
13.93
26,839 USD 		1,927 -0.4% 13.93 26,839 USD
2023-12-14 2023-12-13 S Sale

Thomas John

Non-Executive Director
7,073 -1.5%
13.23
93,548 USD 		7,073 -1.5% 13.23 93,548 USD
2023-12-14 2023-12-13 S Sale

Tyree James L

Non-Executive Director
3,347 -49.2%
13.73
45,963 USD 		3,347 -49.2% 13.73 45,963 USD
2023-12-14 2023-12-13 S Sale

Tyree James L

Non-Executive Director
5,653 -45.4%
12.91
73,006 USD 		5,653 -45.4% 12.91 73,006 USD
2023-12-08 2023-12-07 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
36,800 -53.1%
11.85
435,995 USD 		36,800 -53.1% 11.85 435,995 USD
2023-11-22 2023-11-21 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
18,665 -21.2%
10.26
191,555 USD 		18,665 -21.2% 10.26 191,555 USD
2023-11-21 2023-11-20 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
14,594 -14.2%
11.26
164,261 USD 		14,594 -14.2% 11.26 164,261 USD
2023-11-21 2023-11-17 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
3,541 -3.3%
13.04
46,170 USD 		3,541 -3.3% 13.04 46,170 USD
2023-10-26 2023-10-25 S Sale

Szalay Aladar

Major owner
5,704 -0.4%
19.40
110,638 USD 		5,704 -0.4% 19.40 110,638 USD
2023-10-25 2023-10-24 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
5,200 -4.7%
19.11
99,351 USD 		5,200 -4.7% 19.11 99,351 USD
2023-10-25 2023-10-23 S Sale

Szalay Aladar

Major owner
49,987 -3.5%
19.97
998,365 USD 		49,987 -3.5% 19.97 998,365 USD
2023-10-16 2023-10-16 PS Planned sale

Thomas John

Non-Executive Director
881 -0.2%
21.30
18,769 USD 		881 -0.2% 21.30 18,769 USD
2023-10-16 2023-10-16 PS Planned sale

Thomas John

Non-Executive Director
2,452 -0.5%
20.50
50,269 USD 		2,452 -0.5% 20.50 50,269 USD
2023-10-11 2023-10-10 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
400 -0.4%
22.91
9,162 USD 		400 -0.4% 22.91 9,162 USD
2023-10-11 2023-10-10 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
4,800 -4.3%
21.94
105,300 USD 		4,800 -4.3% 21.94 105,300 USD
2023-10-10 2023-10-05 S Sale

Szalay Aladar

Major owner
985 -0.1%
25.47
25,090 USD 		985 -0.1% 25.47 25,090 USD
2023-10-10 2023-10-05 S Sale

Szalay Aladar

Major owner
13,266 -0.9%
24.89
330,139 USD 		13,266 -0.9% 24.89 330,139 USD
2023-10-04 2023-10-03 S Sale

Szalay Aladar

Major owner
75,690 -5.0%
25.49
1,929,225 USD 		75,690 -5.0% 25.49 1,929,225 USD
2023-09-29 2023-09-28 S Sale

Szalay Aladar

Major owner
2,289 -0.2%
24.12
55,211 USD 		2,289 -0.2% 24.12 55,211 USD
2023-09-29 2023-09-27 S Sale

Szalay Aladar

Major owner
11,257 -0.7%
24.47
275,459 USD 		11,257 -0.7% 24.47 275,459 USD
2023-09-27 2023-09-26 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
2,203 -2.0%
24.46
53,890 USD 		2,203 -2.0% 24.46 53,890 USD
2023-09-27 2023-09-26 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
1,114 -1.0%
23.51
26,195 USD 		1,114 -1.0% 23.51 26,195 USD
2023-09-27 2023-09-26 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
1,883 -1.7%
22.54
42,442 USD 		1,883 -1.7% 22.54 42,442 USD
2023-09-27 2023-09-26 S Sale

Szalay Aladar

Major owner
9,600 -0.6%
24.51
235,296 USD 		9,600 -0.6% 24.51 235,296 USD
2023-09-27 2023-09-26 S Sale

Szalay Aladar

Major owner
12,740 -0.8%
24.03
306,142 USD 		12,740 -0.8% 24.03 306,142 USD
2023-09-27 2023-09-26 S Sale

Szalay Aladar

Major owner
7,465 -0.5%
22.47
167,739 USD 		7,465 -0.5% 22.47 167,739 USD
2023-09-27 2023-09-25 S Sale

Szalay Aladar

Major owner
1,100 -0.1%
27.81
30,591 USD 		1,100 -0.1% 27.81 30,591 USD
2023-09-27 2023-09-25 S Sale

Szalay Aladar

Major owner
1,900 -0.1%
26.60
50,540 USD 		1,900 -0.1% 26.60 50,540 USD
2023-09-27 2023-09-25 S Sale

Szalay Aladar

Major owner
5,511 -0.4%
25.75
141,908 USD 		5,511 -0.4% 25.75 141,908 USD
2023-09-27 2023-09-25 S Sale

Szalay Aladar

Major owner
3,947 -0.3%
24.82
97,965 USD 		3,947 -0.3% 24.82 97,965 USD
2023-09-25 2023-09-22 S Sale

Szalay Aladar

Major owner
4,621 -0.3%
27.76
128,270 USD 		4,621 -0.3% 27.76 128,270 USD
2023-09-25 2023-09-22 S Sale

Szalay Aladar

Major owner
4,421 -0.3%
26.88
118,853 USD 		4,421 -0.3% 26.88 118,853 USD
2023-09-25 2023-09-21 S Sale

Szalay Aladar

Major owner
4,678 -0.3%
28.82
134,815 USD 		4,678 -0.3% 28.82 134,815 USD
2023-09-25 2023-09-21 S Sale

Szalay Aladar

Major owner
2,871 -0.2%
27.89
80,063 USD 		2,871 -0.2% 27.89 80,063 USD
2023-09-21 2023-09-20 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
6,000 -5.4%
27.96
167,786 USD 		6,000 -5.4% 27.96 167,786 USD
2023-09-21 2023-09-20 PS Planned sale

Ryder Sean

General Counsel

Officer
10,000 -94.6%
30.00
300,000 USD 		10,000 -94.6% 30.00 300,000 USD
2023-09-20 2023-09-19 S Sale

Szalay Aladar

Major owner
8,247 -100.0%
27.16
223,979 USD 		8,247 -100.0% 27.16 223,979 USD
2023-09-20 2023-09-19 S Sale

Szalay Aladar

Major owner
23,920 -74.4%
26.21
626,962 USD 		23,920 -74.4% 26.21 626,962 USD
2023-09-20 2023-09-18 S Sale

Szalay Aladar

Major owner
2,927 -36.9%
24.17
70,754 USD 		2,927 -36.9% 24.17 70,754 USD
2023-09-20 2023-09-18 S Sale

Szalay Aladar

Major owner
27,365 -77.5%
23.20
634,895 USD 		27,365 -77.5% 23.20 634,895 USD
2023-09-18 2023-09-18 PS Planned sale

Thomas John

Non-Executive Director
3,334 -0.7%
24.99
83,317 USD 		3,334 -0.7% 24.99 83,317 USD
2023-09-18 2023-09-15 PS Planned sale

Thomas John

Non-Executive Director
1,088 -0.2%
22.38
24,354 USD 		1,088 -0.2% 22.38 24,354 USD
2023-09-18 2023-09-15 PS Planned sale

Thomas John

Non-Executive Director
2,245 -0.5%
21.67
48,642 USD 		2,245 -0.5% 21.67 48,642 USD
2023-09-18 2023-09-15 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
4,675 -4.2%
22.29
104,212 USD 		4,675 -4.2% 22.29 104,212 USD
2023-09-18 2023-09-15 PS Planned sale

Yu Yong

VP, Clinical Trial Operations

Officer
5,725 -4.9%
21.56
123,418 USD 		5,725 -4.9% 21.56 123,418 USD
2023-09-15 2023-09-14 S Sale

Szalay Aladar

Major owner
13,871 -28.2%
22.31
309,522 USD 		13,871 -28.2% 22.31 309,522 USD
2023-09-15 2023-09-14 S Sale

Szalay Aladar

Major owner
11,405 -18.8%
21.77
248,285 USD 		11,405 -18.8% 21.77 248,285 USD
2023-09-15 2023-09-13 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
29,800 -21.9%
21.14
629,927 USD 		29,800 -21.9% 21.14 629,927 USD
2023-09-15 2023-09-13 S Sale

Szalay Aladar

Major owner
3,315 -5.2%
22.31
73,961 USD 		3,315 -5.2% 22.31 73,961 USD
2023-09-15 2023-09-13 S Sale

Szalay Aladar

Major owner
15,717 -19.7%
21.26
334,132 USD 		15,717 -19.7% 21.26 334,132 USD
2023-09-14 2023-09-13 S Sale

Smither John W

Non-Executive Director
900 -11.5%
20.78
18,702 USD 		900 -11.5% 20.78 18,702 USD
2023-09-13 2023-09-12 S Sale

Szalay Aladar

Major owner
13,727 -14.7%
22.51
308,936 USD 		13,727 -14.7% 22.51 308,936 USD
2023-09-13 2023-09-12 S Sale

Szalay Aladar

Major owner
6,538 -6.5%
21.75
142,231 USD 		6,538 -6.5% 21.75 142,231 USD
2023-09-13 2023-09-11 S Sale

Szalay Aladar

Major owner
23,020 -18.7%
22.55
519,156 USD 		23,020 -18.7% 22.55 519,156 USD
2023-09-13 2023-09-11 S Sale

Szalay Aladar

Major owner
9,331 -7.1%
21.39
199,545 USD 		9,331 -7.1% 21.39 199,545 USD
2023-09-11 2023-09-08 S Sale

Szalay Aladar

Major owner
2,636 -2.0%
24.19
63,752 USD 		2,636 -2.0% 24.19 63,752 USD
2023-09-11 2023-09-08 S Sale

Szalay Aladar

Major owner
8,523 -5.9%
23.49
200,169 USD 		8,523 -5.9% 23.49 200,169 USD
2023-09-11 2023-09-08 S Sale

Szalay Aladar

Major owner
13,672 -8.7%
22.78
311,411 USD 		13,672 -8.7% 22.78 311,411 USD
2023-09-11 2023-09-07 S Sale

Szalay Aladar

Major owner
2,508 -1.6%
25.34
63,551 USD 		2,508 -1.6% 25.34 63,551 USD
2023-09-11 2023-09-07 S Sale

Szalay Aladar

Major owner
9,938 -5.9%
24.12
239,716 USD 		9,938 -5.9% 24.12 239,716 USD
2023-08-30 2023-08-30 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
19,800 -12.7%
24.70
489,060 USD 		19,800 -12.7% 24.70 489,060 USD
2023-08-22 2023-08-18 S Sale

Zindrick Thomas

President and CEO

Executive Director
8,349 -36.3%
23.73
198,122 USD 		8,349 -36.3% 23.73 198,122 USD
2023-08-22 2023-08-18 S Sale

Yu Yong

VP, Clinical Trial Operations

Officer
3,265 -2.1%
23.73
77,478 USD 		3,265 -2.1% 23.73 77,478 USD
2023-08-22 2023-08-18 S Sale

Smalling Ralph

Head of Regulatory

Officer
935 -31.2%
23.73
22,188 USD 		935 -31.2% 23.73 22,188 USD
2023-08-22 2023-08-18 S Sale

Ryder Sean

General Counsel

Officer
328 -36.4%
23.73
7,783 USD 		328 -36.4% 23.73 7,783 USD